Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xueshuantong Injection for unstable angina
ChiCTR1800015911Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of xuesetong capsule in unstable angina and coronary arteriosclerosis (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Composite major adverse cardiovascular events. Started Sep 2017; status: recruiting.
02
Drugs
xuesetong capsule
03
Conditions
unstable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800015911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015911.